Article PDF
Avoid common mistakes on your manuscript.
References
Kondo T, Kahn CR. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 2004;279(36):37997–8006.
Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61(3):448–60.
Hlobilkova A, Knillova J, Bartek J, Lukas J, Kolar Z. The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147(1):19–25.
Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004;37(2):449–71.
Cai Z, Semenza GL. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 2005;97(12):1351–9.
Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005;54(8):2360–4.
Mensah K, Mocanu MM, Yellon DM. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 2005;45(8):1287–91.
Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer 2006;118(10):2390–8.
Butler M, McKay RA, Popoff IJ, et al. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 2002;51(4):1028–34.
Kushner JA, Simpson L, Wartschow LM, et al. Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. J Biol Chem 2005;280(47):39388–93.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mocanu, M.M., Field, D.C. & Yellon, D.M. A Potential Role for PTEN in the Diabetic Heart. Cardiovasc Drugs Ther 20, 319–321 (2006). https://doi.org/10.1007/s10557-006-8876-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-006-8876-4